Tokyo, Sept. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059047) titled 'The effect of ingestion of eicosapentaenoic acid and docosahexaenoic acid on peripheral body temperature - A systematic review' on Sept. 10.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Nissui Corporation
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate the effect of ingestion of EPA and DHA on peripheral body temperature
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Healthy adults
Key exclusion criteria - Participants who are suffering from illness, children (persons under 18 years) and pregnant
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 08 Month 26 Day
Anticipated trial start date - 2025 Year 09 Month 10 Day
Last follow-up date - 2025 Year 11 Month 10 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067541
Disclaimer: Curated by HT Syndication.
